Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anxiety Disorders × Dronabinol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Parasomnias 1 Pain 1 Nausea 1 Marijuana Abuse 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Breast Neoplasms 1 Anxiety Disorders 1

Interventions

Psilocybin 4 Psychotherapy 2 Fluoxetine 2 Cannabidiol 2 nabiximols 1 Yoga 1 Therapeutics 1 Pharmaceutical Preparations 1 Niacin 1 Neoadjuvant Therapy 1 N-Methyl-3,4-methylenedioxyamphetamine 1 Minocycline 1 Medical Marijuana 1 Ketamine 1 Injections 1 Hormones 1 Gemcitabine 1 Dronabinol 1 Donepezil 1 Citalopram 1 Cisplatin 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡